{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:29:24Z","timestamp":1759177764922,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health, USA","doi-asserted-by":"crossref","award":["CA177932"],"award-info":[{"award-number":["CA177932"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2010-0029220","2013M3A9D3045879","2013K1A1A2A02050188"],"award-info":[{"award-number":["2010-0029220","2013M3A9D3045879","2013K1A1A2A02050188"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jconrel.2015.09.068","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T14:39:36Z","timestamp":1444228776000},"page":"691-703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"PB","title":["Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy"],"prefix":"10.1016","volume":"220","author":[{"given":"Joung-Woo","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kihoon","family":"Nam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjin","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chae-Ok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SungWan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.09.068_bb0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.mt.6300321","article-title":"Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide","volume":"16","author":"Kreppel","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0010","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumours","volume":"5","author":"Parato","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0015","first-page":"356","article-title":"Overcoming the extracellular matrix barrier to improve intratumoral spread and therapeutic potential of oncolytic virotherapy","volume":"10","author":"Yun","year":"2008","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.addr.2011.12.011","article-title":"Evolution of oncolytic adenovirus for cancer treatment","volume":"64","author":"Choi","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0025","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1089\/hum.2005.16.1016","article-title":"Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers","volume":"16","author":"Peng","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1874467210801010013","article-title":"Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications","volume":"1","author":"Raty","year":"2008","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2006.12.002","article-title":"Cancer selective adenoviruses","volume":"28","author":"Alemany","year":"2007","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0040","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/156652305774964677","article-title":"Adenovirus-based cancer gene therapy","volume":"5","author":"Kaplan","year":"2005","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0045","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.biomaterials.2010.10.031","article-title":"Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.addr.2006.03.007","article-title":"Current status of polymeric gene delivery systems","volume":"58","author":"Park","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403006562","article-title":"Nonviral gene delivery: techniques and implications for molecular medicine","volume":"5","author":"Parker","year":"2003","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0060","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1021\/bc700397x","article-title":"Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity","volume":"19","author":"Ou","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0065","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.biomaterials.2008.10.009","article-title":"Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems","volume":"30","author":"Kim","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0070","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.biomaterials.2009.11.043","article-title":"The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy","volume":"31","author":"Kim","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0075","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1016\/j.biomaterials.2013.03.004","article-title":"Therapeutic efficacy of a systemically delivered oncolytic adenovirus \u2014 biodegradable polymer complex","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0080","doi-asserted-by":"crossref","DOI":"10.1021\/acs.bioconjchem.5b00357","article-title":"Tuning surface charge and PEGylation of biocompatible polymers for efficient delivering of nucleic acid or adenoviral vector","author":"Choi","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1021\/bm501116x","article-title":"Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model","volume":"16","author":"Jung","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0090","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1016\/j.biomaterials.2014.03.060","article-title":"Enhanced therapeutic efficacy of an adenovirus-PEI-bile-acid complex in tumors with low coxsackie and adenovirus receptor expression","volume":"35","author":"Lee","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0095","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1021\/acs.biomac.5b00538","article-title":"Oncolytic adenovirus coated with multidegradable bioreducible core-cross-linked polyethylenimine for cancer gene therapy","volume":"16","author":"Choi","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0100","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0105","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1016\/j.biomaterials.2014.05.021","article-title":"Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery","volume":"35","author":"Kim","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0168-3659(01)00513-2","article-title":"Optimization of factors influencing the transfection efficiency of folate-PEG-folate-graft-polyethylenimine","volume":"79","author":"Benns","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0115","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1021\/mp200589z","article-title":"Cell targeting peptide conjugation to siRNA polyplexes for effective gene silencing in cardiomyocytes","volume":"9","author":"Nam","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0120","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1016\/j.biomaterials.2011.03.084","article-title":"Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2013.03.030","article-title":"Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy","volume":"169","author":"Kwon","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2119\/2006-00115.Zhang","article-title":"Screening and identification of a targeting peptide to hepatocarcinoma from a phage display peptide library","volume":"13","author":"Zhang","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0135","first-page":"3191","article-title":"Gene-carried hepatoma targeting complex induced high gene transfection efficiency with low toxicity and significant antitumor activity","volume":"7","author":"Zhao","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2015.01.005","article-title":"pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis","author":"Choi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0145","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/hum.2006.167","article-title":"E1A- and E1B-double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects","volume":"18","author":"Kim","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0150","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1158\/1078-0432.CCR-12-2791","article-title":"Targeting the HGF\/c-MET pathway in hepatocellular carcinoma","volume":"19","author":"Goyal","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0155","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.18632\/oncotarget.3018","article-title":"Adenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cells","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrc3205","article-title":"Targeting MET in cancer: rationale and progress","volume":"12","author":"Gherardi","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0165","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/362841a0","article-title":"Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo","volume":"362","author":"Kim","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0170","doi-asserted-by":"crossref","first-page":"12718","DOI":"10.1073\/pnas.2135113100","article-title":"Hepatocyte growth factor\/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation","volume":"100","author":"Zhang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0175","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/BC20080221","article-title":"Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells","volume":"101","author":"Sulpice","year":"2009","journal-title":"Biol. Cell."},{"key":"10.1016\/j.jconrel.2015.09.068_bb0180","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.biomaterials.2010.09.045","article-title":"A serum-resistant polyamidoamine-based polypeptide dendrimer for gene transfection","volume":"32","author":"Wu","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.09.068_bb0185","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/mthe.2001.0329","article-title":"Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages","volume":"3","author":"Zhang","year":"2001","journal-title":"Mol. Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915301681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915301681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T09:58:05Z","timestamp":1599645485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915301681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":37,"alternative-id":["S0168365915301681"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.068","relation":{},"ISSN":["0168-3659"],"issn-type":[{"type":"print","value":"0168-3659"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}